Clarissa J. Watts

459 total citations
7 papers, 388 citations indexed

About

Clarissa J. Watts is a scholar working on Physiology, Immunology and Allergy and Pathology and Forensic Medicine. According to data from OpenAlex, Clarissa J. Watts has authored 7 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 4 papers in Immunology and Allergy and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Clarissa J. Watts's work include Asthma and respiratory diseases (4 papers), Allergic Rhinitis and Sensitization (4 papers) and Mast cells and histamine (2 papers). Clarissa J. Watts is often cited by papers focused on Asthma and respiratory diseases (4 papers), Allergic Rhinitis and Sensitization (4 papers) and Mast cells and histamine (2 papers). Clarissa J. Watts collaborates with scholars based in United Kingdom, Netherlands and United States. Clarissa J. Watts's co-authors include J Edelman, John M. Esdaile, R. N. Thompson, Anthony S. Russell, Maria G. Belvisi, Saleem Haj‐Yahia, Sissie Wong, Kwok‐Tao Pun, Mark A. Birrell and Jorge De Alba and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Clarissa J. Watts

7 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clarissa J. Watts United Kingdom 6 129 120 117 72 58 7 388
Taher E. Taher United Kingdom 15 405 3.1× 123 1.0× 190 1.6× 31 0.4× 39 0.7× 23 669
David Soler United States 12 249 1.9× 134 1.1× 35 0.3× 74 1.0× 36 0.6× 26 505
Zhifang Zhai China 14 210 1.6× 97 0.8× 136 1.2× 37 0.5× 33 0.6× 34 414
Andrew C. Palfreeman United Kingdom 8 312 2.4× 124 1.0× 174 1.5× 43 0.6× 23 0.4× 8 497
Noria Harir Algeria 10 174 1.3× 178 1.5× 56 0.5× 15 0.2× 85 1.5× 37 514
Grace I. Wells United States 7 296 2.3× 130 1.1× 47 0.4× 39 0.5× 28 0.5× 8 451
Daniel Torres‐Moreno Spain 12 97 0.8× 114 0.9× 64 0.5× 16 0.2× 23 0.4× 24 399
Anna Wolska Poland 13 205 1.6× 166 1.4× 49 0.4× 16 0.2× 62 1.1× 29 512
Deborah Cluxton Ireland 5 284 2.2× 101 0.8× 69 0.6× 31 0.4× 8 0.1× 5 438
D. Shoham Israel 10 191 1.5× 109 0.9× 39 0.3× 40 0.6× 63 1.1× 14 428

Countries citing papers authored by Clarissa J. Watts

Since Specialization
Citations

This map shows the geographic impact of Clarissa J. Watts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clarissa J. Watts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clarissa J. Watts more than expected).

Fields of papers citing papers by Clarissa J. Watts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clarissa J. Watts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clarissa J. Watts. The network helps show where Clarissa J. Watts may publish in the future.

Co-authorship network of co-authors of Clarissa J. Watts

This figure shows the co-authorship network connecting the top 25 collaborators of Clarissa J. Watts. A scholar is included among the top collaborators of Clarissa J. Watts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clarissa J. Watts. Clarissa J. Watts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Scott, Nicola, Scott B. Berger, Kurt Brown, et al.. (2021). A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis. BMJ Open Gastroenterology. 8(1). e000680–e000680. 65 indexed citations
2.
Procopiou, Panayiotis A., Alison J. Ford, Simon T. Hodgson, et al.. (2017). Design of Phthalazinone Amide Histamine H1 Receptor Antagonists for Use in Rhinitis. ACS Medicinal Chemistry Letters. 8(5). 577–581. 12 indexed citations
3.
Procopiou, Panayiotis A., Alison J. Ford, Ashley P. Hancock, et al.. (2017). Identification of selective 8-(piperidin-4-yloxy)quinoline sulfone and sulfonamide histamine H1 receptor antagonists for use in allergic rhinitis. Bioorganic & Medicinal Chemistry Letters. 27(21). 4914–4919. 2 indexed citations
4.
Procopiou, Panayiotis A., Christopher R. Browning, Kenneth L. Clark, et al.. (2011). The Discovery of Phthalazinone-Based Human H1and H3Single-Ligand Antagonists Suitable for Intranasal Administration for the Treatment of Allergic Rhinitis. Journal of Medicinal Chemistry. 54(7). 2183–2195. 28 indexed citations
5.
Procopiou, Panayiotis A., Mark J. Bamford, Christopher R. Browning, et al.. (2007). 4-Acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a Novel Class of Non-Brain-Penetrant Histamine H3 Receptor Antagonists. Journal of Medicinal Chemistry. 50(26). 6706–6717. 22 indexed citations
6.
Birrell, Mark A., Elizabeth Hardaker, Sissie Wong, et al.. (2005). Iκ-B Kinase-2 Inhibitor Blocks Inflammation in Human Airway Smooth Muscle and a Rat Model of Asthma. American Journal of Respiratory and Critical Care Medicine. 172(8). 962–971. 107 indexed citations
7.
Thompson, R. N., Clarissa J. Watts, J Edelman, John M. Esdaile, & Anthony S. Russell. (1984). A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis.. PubMed. 11(6). 760–3. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taher E. Taher Breakdown of academic impact, for papers by David Soler Breakdown of academic impact, for papers by Zhifang Zhai Breakdown of academic impact, for papers by Andrew C. Palfreeman Breakdown of academic impact, for papers by Noria Harir Breakdown of academic impact, for papers by Grace I. Wells Breakdown of academic impact, for papers by Daniel Torres‐Moreno Breakdown of academic impact, for papers by Anna Wolska Breakdown of academic impact, for papers by Deborah Cluxton Breakdown of academic impact, for papers by D. Shoham
Rankless by CCL
2026